« Back to Record
Citation APA

Berghmans, T., Lafitte, J.-J., Paesmans, M., Meert, A.-P., Scherpereel, A., Leclercq, N., & Sculier, J.-P. (s.d.). A phase III randomised trial assessing the activity of first-line ifosfamide-gemcitabine (IG), a non-platinum chemotherapy (CT), in patients with advanced non small cell lung cancer (NSCLC). Paper session presented at European respiratory Society Annual Congress (2011: Amsterdam, The Netherlands).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/113225

Berghmans, T., Lafitte, J.-J., Paesmans, M., Meert, A.-P., Scherpereel, A., Leclercq, N., & Sculier, J.-P. (s.d.). A phase III randomised trial assessing the activity of first-line ifosfamide-gemcitabine (IG), a non-platinum chemotherapy (CT), in patients with advanced non small cell lung cancer (NSCLC). Paper session presented at European respiratory Society Annual Congress (2011: Amsterdam, The Netherlands).